OBJECTIVE:Intermittent theta burst stimulation (iTBS) is increasingly widely used as a means of facilitating corticospinal excitability in the human primary motor cortex. This form of facilitatory plasticity within the stimulated cortex may occur by induction of long term potentiation (LTP). In animal models, agonists of nicotinic acetylcholine receptors have been shown to modulate or induce LTP; we thus sought to test whether nicotine may modulate the effects of iTBS on corticospinal excitability in humans. METHODS: A double-blind placebo-controlled cross-over design study was conducted with 10 healthy subjects. iTBS was delivered 60min after subjects took either 4mg nicotine or placebo lozenges, and motor-evoked potentials (MEPs) were then recorded for 40min after the end of stimulation. RESULTS: In the placebo arm, iTBS produced an increase in the amplitudes of MEPs which lasted for 5min. In the nicotine arm, iTBS produced a more pronounced facilitation of MEPs that was still present at 40min. In a control experiment, nicotine alone had no effect on MEP amplitudes when given in the absence of iTBS. CONCLUSIONS: These data indicate that the effects of iTBS can be enhanced and prolonged by nicotine. SIGNIFICANCE: These results are consistent with animal models demonstrating nicotinic modulation of facilitatory plasticity, and will be of interest to investigators seeking to enhance artificially induced changes in cortical excitability.
RCT Entities:
OBJECTIVE: Intermittent theta burst stimulation (iTBS) is increasingly widely used as a means of facilitating corticospinal excitability in the human primary motor cortex. This form of facilitatory plasticity within the stimulated cortex may occur by induction of long term potentiation (LTP). In animal models, agonists of nicotinic acetylcholine receptors have been shown to modulate or induce LTP; we thus sought to test whether nicotine may modulate the effects of iTBS on corticospinal excitability in humans. METHODS: A double-blind placebo-controlled cross-over design study was conducted with 10 healthy subjects. iTBS was delivered 60min after subjects took either 4mg nicotine or placebo lozenges, and motor-evoked potentials (MEPs) were then recorded for 40min after the end of stimulation. RESULTS: In the placebo arm, iTBS produced an increase in the amplitudes of MEPs which lasted for 5min. In the nicotine arm, iTBS produced a more pronounced facilitation of MEPs that was still present at 40min. In a control experiment, nicotine alone had no effect on MEP amplitudes when given in the absence of iTBS. CONCLUSIONS: These data indicate that the effects of iTBS can be enhanced and prolonged by nicotine. SIGNIFICANCE: These results are consistent with animal models demonstrating nicotinic modulation of facilitatory plasticity, and will be of interest to investigators seeking to enhance artificially induced changes in cortical excitability.
Authors: Marc R Kamke; Michelle G Hall; Hayley F Lye; Martin V Sale; Laura R Fenlon; Timothy J Carroll; Stephan Riek; Jason B Mattingley Journal: J Neurosci Date: 2012-05-16 Impact factor: 6.167
Authors: Nivethida Thirugnanasambandam; Jessica Grundey; Kim Adam; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche Journal: Neuropsychopharmacology Date: 2010-12-15 Impact factor: 7.853
Authors: Marielle Young-Bernier; Annick N Tanguay; Patrick S R Davidson; François Tremblay Journal: Front Aging Neurosci Date: 2014-08-07 Impact factor: 5.750
Authors: Jessica Grundey; Nivethida Thirugnanasambandam; Kim Kaminsky; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche Journal: Front Pharmacol Date: 2012-10-26 Impact factor: 5.810